Stocks and Investing
Stocks and Investing
Fri, March 8, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Ed Arce Reiterated (UNCY) at Strong Buy and Held Target at $4.5 on, Mar 8th, 2024
Ed Arce of HC Wainwright & Co., Reiterated "Unicycive Therapeutics, Inc." (UNCY) at Strong Buy and Held Target at $4.5 on, Mar 8th, 2024.
Ed has made no other calls on UNCY in the last 4 months.
There are 2 other peers that have a rating on UNCY. Out of the 2 peers that are also analyzing UNCY, 0 agree with Ed's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Ed
- Robert LeBoyer of "Noble Capital Markets" Initiated at Buy and Held Target at $6 on, Wednesday, February 14th, 2024
- Bruce Jackson of "Benchmark" Reiterated at Buy and Held Target at $3 on, Monday, December 4th, 2023
Contributing Sources